R&D Digital Transformation
Leading operating model redesign and embedding data-driven decision-making into regulated R&D workflows — drawing on hands-on experience at AstraZeneca and Boehringer Ingelheim spanning early clinical through late-stage development.
Scientific Communications & Thought Leadership
Translating complex scientific and clinical data into clear, decision-enabling narratives for internal and external audiences — regulators, payers, advocacy groups, and the broader medical community.
Medical Affairs & Launch Strategy
Drawing on deep experience in global medical affairs and launch excellence across immunology, respiratory, CVRM, and specialty medicines to support asset differentiation, lifecycle planning, and market access strategy.
Clinical AI Strategy & Programme Design
Defining and delivering AI/ML strategies in translational and early clinical development settings — from use-case identification and prioritisation through to governance frameworks, KPI design, and ROI quantification. Recent work includes commissioned programme design for a £50M UK government AI sensing initiative (ARIA).
AI Vendor & Technology Assessment
Evaluating AI/ML tools, digital health technologies, and external partnerships for fit within complex pharmaceutical R&D environments — bridging the gap between technical capability and clinical applicability.
Translational Research & Evidence Generation
Designing evidence generation strategies across the full development continuum — Phase 1 through Phase 4 and real-world outcomes — integrating RWE, HEOR, and advanced analytics to build commercially compelling, scientifically rigorous data packages.
Services
Filters
No results found
No results match your search. Try removing a few filters.